Thermo Fisher Launches TacroType Test As Shares Trade Below Targets [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Thermo Fisher Scientific (NYSE:TMO) launched its TacroType Pharmacogenetic Test for transplant patients. The test is designed to support more personalized tacrolimus dosing based on a patient's genetic profile. The product targets transplant centers and clinicians involved in post transplant medication management. Thermo Fisher Scientific, traded as NYSE:TMO, is a large player in life sciences tools and diagnostics, supplying instruments, tests and services across research and clinical settings. The TacroType Pharmacogenetic Test fits into broader interest in using genetics to guide drug dosing, particularly in areas like organ transplantation where medication levels are tightly managed. For investors watching NYSE:TMO, this launch is another example of the company releasing products that align with personalized medicine trends in clinical care. The focus will
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies [Yahoo! Finance]Yahoo! Finance
- [Latest] Global Microplate Systems Market Size/Share Worth USD 2.88 Billion by 2035 at a 10.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]Latest
- 4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer [Yahoo! Finance]Yahoo! Finance
- Chemical Concentration Monitor Industry Research and Global Market Forecast Report 2025-2030 [Yahoo! Finance]Yahoo! Finance
- IVIS?????????? ???????? - ??????????????????2026-2035? [CNET News]CNET News
TMO
Earnings
- 1/29/26 - Beat
TMO
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 144
- 3/4/26 - Form 144
- TMO's page on the SEC website